Trial · NCT03291379
Results by group107
Each measurement the trial posted, group by group, in the words and numbers it posted.
41 to 60 of 107
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 01: N-desmethyl Vandetanib concentration edge of tumour | 3680 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 01: N-desmethyl Vandetanib concentration 1cm away from tumour | 280 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 03: N-desmethyl concentration centre of tumour | 69.6 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 03: N-desmethyl Vandetanib concentration middle of tumour | 59.8 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 03: N-desmethyl Vandetanib concentration edge of tumour | 69.2 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 03: N-desmethyl Vandetanib concentration 1cm away from tumour | 831 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 05: N-desmethyl concentration centre of tumour | 421 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 05: N-desmethyl Vandetanib concentration middle of tumour | 418 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 05: N-desmethyl Vandetanib concentration edge of tumour | 469 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 05: N-desmethyl Vandetanib concentration 1cm away from tumour | 544 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 06: N-desmethyl concentration centre of tumour | 113 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 06: N-desmethyl Vandetanib concentration middle of tumour | 93.9 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 06: N-desmethyl Vandetanib concentration edge of tumour | 11.4 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 06: N-desmethyl Vandetanib concentration 1cm away from tumour | 55.6 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 07: N-desmethyl concentration centre of tumour | 21 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 07: N-desmethyl Vandetanib concentration middle of tumour | 15.7 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 07: N-desmethyl Vandetanib concentration edge of tumour | 28.7 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 07: N-desmethyl Vandetanib concentration 1cm away from tumour | 84 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 08: N-desmethyl concentration centre of tumour | 39.3 | ng/mL | |
| Concentration of N-desmethyl Vandetanib in Resected Liver Tissue Following Treatment With BTG-002814 | BTG-002814 | Subject 08 (1cm lesion): whole tumour N-desmethyl concentration | 208 | ng/mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03291379/results?page=3